ATE526033T1 - Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen - Google Patents

Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen

Info

Publication number
ATE526033T1
ATE526033T1 AT03755451T AT03755451T ATE526033T1 AT E526033 T1 ATE526033 T1 AT E526033T1 AT 03755451 T AT03755451 T AT 03755451T AT 03755451 T AT03755451 T AT 03755451T AT E526033 T1 ATE526033 T1 AT E526033T1
Authority
AT
Austria
Prior art keywords
culture
vitro
sporozoea
procedure
applications
Prior art date
Application number
AT03755451T
Other languages
English (en)
Inventor
Siobhan Ellison
Original Assignee
Schering Plough Ltd
Pathogenes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd, Pathogenes Inc filed Critical Schering Plough Ltd
Application granted granted Critical
Publication of ATE526033T1 publication Critical patent/ATE526033T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT03755451T 2002-05-21 2003-05-20 Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen ATE526033T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38242802P 2002-05-21 2002-05-21
PCT/US2003/016302 WO2003099325A1 (en) 2002-05-21 2003-05-20 Methods for the in vitro culture of sporozoea sp. and user thereof

Publications (1)

Publication Number Publication Date
ATE526033T1 true ATE526033T1 (de) 2011-10-15

Family

ID=29584411

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03755451T ATE526033T1 (de) 2002-05-21 2003-05-20 Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen

Country Status (10)

Country Link
US (2) US7250286B2 (de)
EP (1) EP1506005B1 (de)
JP (2) JP4495586B2 (de)
CN (2) CN100528225C (de)
AT (1) ATE526033T1 (de)
AU (1) AU2003231818B2 (de)
CA (1) CA2486618C (de)
IL (1) IL165106A (de)
MX (1) MXPA04011514A (de)
WO (1) WO2003099325A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
US8110188B2 (en) * 2003-03-18 2012-02-07 Investigacion Aplicada, S.A. De C.V. Compositions for prevention and treatment of infections caused by coccidia in chickens
CA2586093A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Methods for cultivating lawsonia intracellularis
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
AU2006308534B2 (en) * 2005-11-01 2013-02-07 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
CN100366726C (zh) * 2006-04-07 2008-02-06 佛山市正典生物技术有限公司 一种球虫卵囊培养和保存用溶液及使用方法
US20080194006A1 (en) * 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
MX2010012869A (es) * 2008-05-29 2010-12-14 Intervet Int Bv Vacunas contra coccidiosis.
MX2011005133A (es) * 2008-11-13 2011-08-04 Intervet Int Bv Vacuna contra eimeria para pavos.
AU2012287513A1 (en) 2011-07-22 2014-03-13 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Methods and compositions for vaccinating against Staphylococcus aureus
AU2014227748B2 (en) 2013-03-15 2019-02-14 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for treating fungal and bacterial pathogens
US10393768B2 (en) * 2015-12-28 2019-08-27 Invensense, Inc. MEMS device to selectively measure excitation in different directions
CN107019797B (zh) * 2016-01-30 2020-07-03 天津赫莱恩特生物科技有限公司 一种提高球虫卵囊穿透细胞能力的组合物及其制备方法
CN107019799A (zh) * 2016-01-30 2017-08-08 天津赫莱恩特生物科技有限公司 一种鸡球虫病四价弱毒活疫苗组合物在生产中的应用
JP2019507759A (ja) 2016-03-09 2019-03-22 ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター 外陰部膣カンジダ症の予防及び治療で使用するための方法及びキット
CN108392469A (zh) * 2018-04-08 2018-08-14 广州市汇鑫动物药业有限公司 硫普罗宁在制备抗柔嫩艾美耳球虫药物中的应用
CN112094699B (zh) * 2020-09-27 2023-03-28 广西壮族自治区林业科学研究院 一种樟树纯露的提取方法
CN113661949B (zh) * 2021-07-29 2023-01-13 天津海友佳音生物科技股份有限公司 一种提高卤虫卵稳定性的加工方法
WO2025233315A1 (en) 2024-05-07 2025-11-13 Veterinärmedizinische Universität Wien Novel immunological composition against cystoisospora suis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147186A (en) 1961-04-03 1964-09-01 Auburn Res Foundation Stable coccidiosis immunization
FR2408351A1 (fr) 1977-11-14 1979-06-08 Unilever Nv Procede et composition destines a la lutte contre la coccidiose chez la volaille
JPS5780325A (en) 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
DE3267832D1 (en) 1981-10-23 1986-01-16 Merck & Co Inc In vitro production of intracellular protozoa
US4650676A (en) * 1983-08-19 1987-03-17 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp.
EP0453055B1 (de) 1985-12-03 1997-09-03 Dimminaco Ag/Sa/Ltd. Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
US4808404A (en) 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
US5068104A (en) 1988-08-01 1991-11-26 A. H. Robins Company Incorporated Live vaccine for coccidiosis utilizing coccidial sporozoites
US5005592A (en) 1989-10-27 1991-04-09 Becton Dickinson And Company Method and apparatus for tracking catheters
ES2137190T3 (es) 1991-07-12 1999-12-16 Pfizer Linea de celulas continua y vacuna contra los coccidios aviarios.
US5311841A (en) 1992-07-10 1994-05-17 Thaxton J Paul Administration of medicaments of poultry
AU5989894A (en) 1993-01-19 1994-08-15 Merck & Co., Inc. Live coccidiosis vaccine
DK0831897T3 (da) * 1995-06-07 2001-04-30 Pfizer In ovo-vaccination mod coccidiosis
US5861160A (en) * 1995-06-07 1999-01-19 Ambico, Inc. Isospora suis sporozoite antigen
ES2158108T3 (es) 1995-06-07 2001-09-01 Pfizer Vacunacion in ovo contra la coccidiosis.
BR9713312B1 (pt) * 1996-09-30 2009-08-11 preparado de vacina para uso veterinário útil para produzir imunidade ativa contra uma doença bacteriana ou protozoária.
CA2213385A1 (en) * 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
US6071737A (en) 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses
BR0110232A (pt) 2000-04-25 2003-01-21 Wyeth Corp Vacina para mioencefalite equina causada por protozoário
US6808714B2 (en) 2000-09-22 2004-10-26 University Of Florida Detection of sarcocystis neurona

Also Published As

Publication number Publication date
CA2486618A1 (en) 2003-12-04
AU2003231818A1 (en) 2003-12-12
WO2003099325A1 (en) 2003-12-04
HK1070820A1 (en) 2005-06-30
IL165106A (en) 2010-12-30
EP1506005A1 (de) 2005-02-16
US7250286B2 (en) 2007-07-31
US7816118B2 (en) 2010-10-19
MXPA04011514A (es) 2005-08-15
CN100528225C (zh) 2009-08-19
AU2003231818C1 (en) 2003-12-12
EP1506005B1 (de) 2011-09-28
US20070224223A1 (en) 2007-09-27
JP2005529595A (ja) 2005-10-06
CN1652816A (zh) 2005-08-10
US20040018215A1 (en) 2004-01-29
JP4495586B2 (ja) 2010-07-07
CA2486618C (en) 2013-04-09
IL165106A0 (en) 2005-12-18
JP2010022378A (ja) 2010-02-04
EP1506005A4 (de) 2005-10-12
CN101596312A (zh) 2009-12-09
AU2003231818B2 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
ATE526033T1 (de) Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
DK1664318T3 (da) L-aminosyre-producerende mikroorganisme og fremgangsmåde til fremstilling af L-aminosyre
ECSP11010873A (es) Método de cultivo continuo, recolección y extracción de un microorganismo fotosíntetico
EP1472338A4 (de) Modulation von sulfatpermease zur photosynthetischen wasserstoffproduktion
MX356086B (es) Produccion de acidos grasos y derivados de los mismos.
EA200900286A1 (ru) Модификация бактерий для получения этанола
CY1107771T1 (el) Μεθοδος για την παραγωγη χονδρινων εμφυτευματων απο in vitro καλλιεργημενα χονδροκυτταρα
BR112012019874A2 (pt) "armações organometálicas derivadas a partir de metais carbenofilicos e método de produção das mesmas."
MA32255B1 (fr) Procede pour la preparation de triamides a partir d'ammmoniac et d'amidodichlorures
BRPI0718114A2 (pt) método para estimular a produção de fator de crescimento por células de sangue de cordão umbilical humano, método in vitro para expandir células de sangue de cordão umbilical humano, e, método para melhorar sobrevivência e crescimento de células de sangue de cordão umbilical humano transplantadas em um indivíduo
ATE370224T1 (de) Verfahren zur herstellung von l-cystein unter verwendung eines zur gattung escherichia gehörenden bakteriums
ZA202402071B (en) Lyse variant and method for producing l-arginine by using same
ZA202201894B (en) Method for in vitro production of hyaline cartilage tissue
EP2211625A4 (de) Pilzstämme und ein verfahren zur herstellung eines insektizids von diesen stämmen
ATE521697T1 (de) Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion
EA200900984A1 (ru) Улучшение клеточного роста
ATE415470T1 (de) Herstellungsverfahren für iturin a und dessen homologe
BR0013857A (pt) Processo de produção de exopolissacarìdeos, e, exopolissacarìdeo
ES2530760T3 (es) Peptidasas de basidiomicetos
DK1751273T3 (da) Forbindelse WS727713
CO5570711A2 (es) Metodo para preparar heparina de cultivos de mastocitos
DE602006011148D1 (de) Leptospirose-kulturverfahren
EP1558735A4 (de) Uroplakin-ii-promotor aus schwein und verfahren zur herstellung nützlicher proteine unter verwendung des promotors
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties